Transforming global genetic data into medical decisions

Our goal is the rapid medical diagnosis of inherited diseases, provided at the earliest possible moment as we turn analytical information into actionable results for physicians, patients and pharmaceutical partners.

Our commitment to the global medical community is an early and precise diagnosis for continuous improvement of therapeutic options for each individual patient.

 

 


New address as of December 11, 2017

CENTOGENE AG
Am Strande 7
18055 Rostock
Germany


CentoWebinar

Watch our webinar "Biomarkers at CENTOGENE - Individualize your patient's therapy" on demand

Watch on demand

Our Latest Scientific News


Testimonials

Dear Prof. Rolfs, ...

[...] Centogene team participation contributed immensely to our event. It's amazing how much value you offered to our specialists looking to learn about rare diseases and new genomic technologies. Read more...

Romania, March 2017

Dear colleagues, ...

... the world's best laboratory Centogene!

Ukraine, December 2016

Congratulation ...

... for this success. The secret key of such achievement is the continuous unlimited help, collaboration, dedication and hard work from Centogene team. Special thanks to Daniel and Rami. Looking forward for more publications togother in the near future.

Riyadh, November 2016

I am an experienced neurogeneticist ...

and moved back to Lebanon from the US wanting to make a difference in the diagnosis, care and prevention of recurring neurogenetic disorders in the Lebanese. Alas, I was only partially successful, ... Read more

Lebanon, January 2016

Thank you ...

... very much for your unlimited help and support.

Saudi-Arabia, December 2015

Subscribe to our Newsletter

The Ship of Tolerance, a global art project, initiated 2005 and driven over the past years by the artists Ilya & Emilia Kabakov, will be shown for the first...

Read more

Today CENTOGENE and QIAGEN announce to collaborate in bioinformatics for genetic diseases, aiding the analysis of hereditary disorders by integrating genomic...

Read more

CENTOGENE is proud to announce that it received the Continuation of Accreditation Notice for the CAP 15189 Accreditation Program by the College of American...

Read more

CENTOGENE is raising venture capital to strengthen its R&D activities and drive its global growth.

Read more

CENTOGENE has recently added the following single gene tests and Next Generation Sequencing panels to its portfolio. CENTOGENE‘s NGS panel composition always...

Read more

An agreement was recently signed for an exciting new collaboration between CENTOGENE, Germany and University Hospital St. Ivan Rilski Sofia, Bulgaria.

Read more

CENTOGENE is proud to announce today our Euro 25 million financing round led by TVM Capital Life Science in cooperation with DPE Deutsche Private Equity,...

Read more

CENTOGENE AG (CENTOGENE) has been working together for years with local, national, and international partners in developing biomarkers to be used in the early...

Read more

Another milestone is reached for our new headquarter in Rostock: Yesterday, we celebrated together with colleagues, friends and partners the Roofing Ceremony....

Read more